Sort by
Refine Your Search
-
to assess the clinical applicability of cyclin-dependent kinase inhibitors (CKIs) as a novel treatment option for GBM patients. By combining, 3D cultures, cancer stem cell populations, large scale high
-
stem cells (iPSCs) and kidney organoids. These preclinical studies will provide the justification, and inform the appropriate dosing regimen, for future human clinical trials. The primary focus
Enter an email to receive alerts for stem-cell "https:" positions